FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10968011000001104: Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
72951000001112 Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
72961000001110 Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Is a Darifenacin 7.5mg modified-release tablets true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Is a Darifenacin 7.5mg m/r tablet false Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has active ingredient Genitourinary smooth muscle relaxant false Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has active ingredient Darifenacin false Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Is a Emselex true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Darifenacin true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has specific active ingredient Darifenacin hydrobromide true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has active ingredient Darifenacin hydrobromide true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Has basis of strength substance Darifenacin true Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Is a Darifenacin 7.5mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Is pack of False Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier
Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has AMP True Emselex 7.5mg modified-release tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start